【24h】

TMT-HCC: A tool for text mining the biomedical literature for hepatocellular carcinoma (HCC) biomarkers identification

机译:TMT-HCC:用于文本挖掘生物医学文献以鉴定肝细胞癌(HCC)生物标志物的工具

获取原文
获取原文并翻译 | 示例
           

摘要

Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide. New insights into the pathogenesis of this lethal disease are urgently needed. Chromosomal copy number alterations (CNAs) can lead to activation of oncogenes and inactivation of tumor suppressors in human cancers. Thus, identification of cancer-specific CNAs will not only provide new insight into understanding the molecular basis of tumor genesis but also facilitate the identification of HCC biomarkers using CNA. This paper presents the TMT-HCC system; it is a tool for text mining the biomedical literature for hepatocellular carcinoma (HCC) biomarkers identification. TMT-HCC provides researchers with a powerful way to identify and discern molecular biomarkers of HCC to inform diagnosis, prognosis, and treatment driver genes with causal roles in carcinogenesis is to detect genomic regions that under frequent alterations in cancers (CNAs). TMT-HCC also extracts protein-protein interactions from the full text of the scientific papers. The results provided that the integration of genomic and transcriptional data offers powerful potential for identifying novel cancer genes in HCC pathogenesis.
机译:肝细胞癌(HCC)是全球癌症相关死亡率的第三个主要原因。迫切需要对这种致命疾病的发病机理有新的见解。染色体拷贝数改变(CNA)可以导致人类​​癌症中癌基因的激活和肿瘤抑制因子的失活。因此,癌症特异性CNA的鉴定不仅将为了解肿瘤发生的分子基础提供新的见解,而且还将有助于使用CNA鉴定HCC生物标志物。本文介绍了TMT-HCC系统;它是文本挖掘生物医学文献以鉴定肝细胞癌(HCC)生物标志物的工具。 TMT-HCC为研究人员提供了一种强大的方法,可以识别和辨别HCC的分子生物标志物,以告知诊断,预后和治疗在致癌性中起因作用的驱动基因,以检测在癌症(CNA)频繁变化的基因组区域。 TMT-HCC还从科学论文的全文中提取蛋白质-蛋白质相互作用。结果提供了基因组和转录数据的整合提供了在HCC发病机理中鉴定新型癌症基因的强大潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号